5HI5

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.219 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.202 

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history


Literature

Binding site elucidation and structure guided design of macrocyclic IL-17A antagonists.

Liu, S.Dakin, L.A.Xing, L.Withka, J.M.Sahasrabudhe, P.V.Li, W.Banker, M.E.Balbo, P.Shanker, S.Chrunyk, B.A.Guo, Z.Chen, J.M.Young, J.A.Bai, G.Starr, J.T.Wright, S.W.Bussenius, J.Tan, S.Gopalsamy, A.Lefker, B.A.Vincent, F.Jones, L.H.Xu, H.Hoth, L.R.Geoghegan, K.F.Qiu, X.Bunnage, M.E.Thorarensen, A.

(2016) Sci Rep 6: 30859-30859

  • DOI: 10.1038/srep30859
  • Primary Citation of Related Structures:  
    5HI3, 5HI5, 5HI4

  • PubMed Abstract: 
  • Interleukin-17A (IL-17A) is a principal driver of multiple inflammatory and immune disorders. Antibodies that neutralize IL-17A or its receptor (IL-17RA) deliver efficacy in autoimmune diseases, but no small-molecule IL-17A antagonists have yet progressed into clinical trials ...

    Interleukin-17A (IL-17A) is a principal driver of multiple inflammatory and immune disorders. Antibodies that neutralize IL-17A or its receptor (IL-17RA) deliver efficacy in autoimmune diseases, but no small-molecule IL-17A antagonists have yet progressed into clinical trials. Investigation of a series of linear peptide ligands to IL-17A and characterization of their binding site has enabled the design of novel macrocyclic ligands that are themselves potent IL-17A antagonists.


    Organizational Affiliation

    Worldwide Medicinal Chemistry, Pfizer Worldwide R&D, 610 Main Street, Cambridge, MA 02139, USA.



Macromolecules
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 1
MoleculeChainsSequence LengthOrganismDetailsImage
Interleukin-17AA, B132Homo sapiensMutation(s): 0 
Gene Names: IL17ACTLA8IL17
UniProt & NIH Common Fund Data Resources
Find proteins for Q16552 (Homo sapiens)
Explore Q16552 
Go to UniProtKB:  Q16552
PHAROS:  Q16552
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetailsImage
CAT-2000 FAB heavy chainC, E [auth H]237Homo sapiensMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  Structure
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetailsImage
CAT-2000 light chainD, G [auth L]214Homo sapiensMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
  • Find similar proteins by:  Sequence   |   Structure
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetailsImage
synthetic IL-17A inhibitorF [auth I]16synthetic constructMutation(s): 0 
Protein Feature View
Expand
  • Reference Sequence
Small Molecules
Ligands 1 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
63Q (Subject of Investigation/LOI)
Query on 63Q

Download Ideal Coordinates CCD File 
H [auth B](4S,20R)-7-chloro-N-methyl-4-{[(1-methyl-1H-pyrazol-5-yl)carbonyl]amino}-3,18-dioxo-2,19-diazatetracyclo[20.2.2.1~6,10~.1~11,15~]octacosa-1(24),6(28),7,9,11(27),12,14,22,25-nonaene-20-carboxamide
C33 H33 Cl N6 O4
CEFRORFLEYHRHI-IZLXSDGUSA-N
 Ligand Interaction
Binding Affinity Annotations 
IDSourceBinding Affinity
63Q Binding MOAD:  5HI5 IC50: 9 (nM) from 1 assay(s)
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.80 Å
  • R-Value Free: 0.219 
  • R-Value Work: 0.201 
  • R-Value Observed: 0.202 
  • Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 91.32α = 90
b = 68.68β = 90.65
c = 100.53γ = 90
Software Package:
Software NamePurpose
BUSTERrefinement
AutoPROCdata scaling
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment  



Entry History 

Deposition Data

  • Deposited Date: 2016-01-11 
  • Released Date: 2016-08-31 
  • Deposition Author(s): Liu, S.

Revision History  (Full details and data files)

  • Version 1.0: 2016-08-31
    Type: Initial release
  • Version 1.1: 2017-11-22
    Changes: Derived calculations, Refinement description